Rajeev M. Shah, Director, 10% Owner at Aerovate Therapeutics, Inc. (AVTE), bought 1,856,220 shares at $1.67 ($3.1M) on 2024-06-17, disclosed to the SEC on 2024-06-20.
Open-market purchase of $3.1M AVTE by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.67 | 928,110 | $1.5M | 50.0% |
| 2 | $1.67 | 928,110 | $1.5M | 50.0% |
| Total | $1.67 avg | 1,856,220 | $3.1M | 100% |
| Filing → |
| SEPN | BUY | 2024-10-30 | $75.1M | — | Filing → |
| HOWL | BUY | 2023-01-10 | $4.1M | — | Filing → |
| IMRA | BUY | 2022-12-12 | $191K | — | Filing → |